Page 2804 - Saunders Comprehensive Review For NCLEX-RN

chronic kidney disease manifestations in 763b

in cystic fibrosis 438–439
physiological maternal changes in 268–269

positioning clients in 209

Research consent 63b
Resin uptake test, T and T 580
3
4
Resistance, to change 78, 78b

Respirations 122–123
of adolescent 237b

assessment of 834b
near-death physiological manifestations in 240

of newborn 232b, 340
in postpartum vital signs 326t

of preschooler 235b
of school-age child 237b

of toddler 234b
Respiratory acidosis 111–112, 112b, 113t, 115, 115t

Respiratory alkalosis 112–113, 113b, 113t, 115, 115t

Respiratory distress, in newborn 344
Respiratory distress syndrome 363

in newborn 349
Respiratory medications 678–694

anticholinergics 679–680, 679b
antihistamines 681, 681b

antitussives 682, 682b
bronchodilators 678–679, 679b

expectorants and mucolytic agents 682, 682b
glucocorticoids 679b, 680

for influenza 688–690, 688b

inhalation devices for 678, 679f
inhaled nonsteroidal antiallergy agent 679b, 680

leukotriene modifiers 679b, 680
monoclonal antibody 680–681

multidrug-resistant strain of tuberculosis (MDR-TB) 683

2804